Inozyme Pharma Stock (NASDAQ: INZY) stock price, news, charts, stock research, profile.
You can purchase shares of Inozyme Pharma (NASDAQ:INZY) through any online brokerage.
Other companies in Inozyme Pharma’s space includes: Macrogenics (NASDAQ:MGNX), Molecular Partners (NASDAQ:MOLN), Precigen (NASDAQ:PGEN), Tevogen Bio Holdings (NASDAQ:TVGN) and Kyverna Therapeutics (NASDAQ:KYTX).
Inozyme Pharma has a consensus price target of $14.88.
The stock price for Inozyme Pharma (NASDAQ: INZY) is $3.06 last updated December 12, 2024 at 7:10 PM EST.
There are no upcoming dividends for Inozyme Pharma.
Inozyme Pharma’s Q4 earnings are confirmed for Tuesday, March 11, 2025.
There is no upcoming split for Inozyme Pharma.
Inozyme Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.